Tamsulosin Hydrochloride Capsule
Product Images NDC 60760-598

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 60760-598). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary�s Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tamsulosin 60760 598 90

This is a description of Tamsulosin Hydrochloride Capsules, USP 0.4mg. The bottle contains 90 capsules with the NDC code 60760-598-90, Lot number 222277?, and expiration date 72-77. The medication is manufactured by Aurobindo Pharma USA, located at East Windosor in NJ, made in India. The label also provides directions for use and storage temperature recommendations.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

This appears to be a figure with two graphs showing the mean plasma concentrations of tamsulosin hydrochloride capsules 0.4 mg under fasted and fed conditions. The x-axis shows time in hours, while the y-axis shows the concentration of the drug.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

This appears to be a figure (Figure 2A) displaying the mean change from baseline in Total AUA Symptom Score (measured on a scale of 0 to 35) in Study 1. The figure compares the results of the treatment (0.08mg) to a placebo over a duration of 13 weeks using LOCF analysis. The number of participants (n) in each group is provided. No further information is available from the given text.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

The figure 3A shows the mean increase in peak urine flow rate in L/sec for study 1. The treatment groups include 0.08mg, 0.4mg, and Placebo. The mean change in mL/sec is shown over the duration of treatment in weeks. There were different sample sizes for each group ranging from 621 to 755.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

This text appears to be a figure caption or title related to a study investigating the mean increase in peak urine flow rate. The figure shows the results of Study 2 and displays the change in flow rate (measured in mL/Sec) over the course of 20 weeks of treatment. There are also some unreadable characters present.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.